Issuance and Sale of the Securities. At the Closing, the Company shall issue and sell to the Investor, and such Investor shall purchase from the Company, (i) 1,296,296 Shares at a purchase price equal to $0.27 per Share (the “Purchase Price”), for aggregate gross proceeds of $349,999.92 and (ii) a Warrant to purchase 518,518 Warrant Shares, representing 40% of the Shares purchased by the Investor, at an exercise price of $0.38 per share.
Appears in 1 contract
Samples: Securities Purchase Agreement (Regenerx Biopharmaceuticals Inc)
Issuance and Sale of the Securities. At the Closing, the Company shall issue and sell to the Investor, and such Investor shall purchase from the Company, (i) 1,296,296 1,296,297 Shares at a purchase price equal to $0.27 per Share (the “Purchase Price”), for aggregate gross proceeds of $349,999.92 350,000.19 and (ii) a Warrant to purchase 518,518 518,519 Warrant Shares, representing 40% of the Shares purchased by the Investor, at an exercise price of $0.38 per share.
Appears in 1 contract
Samples: Securities Purchase Agreement (Regenerx Biopharmaceuticals Inc)
Issuance and Sale of the Securities. At the Closing, the Company shall issue and sell to the Investor, and such Investor shall purchase from the Company, (i) 1,296,296 925,926 Shares at a purchase price equal to $0.27 per Share (the “Purchase Price”), for aggregate gross proceeds of $349,999.92 250,000.02 and (ii) a Warrant to purchase 518,518 370,370 Warrant Shares, representing 40% of the Shares purchased by the Investor, at an exercise price of $0.38 per share.
Appears in 1 contract
Samples: Securities Purchase Agreement (Regenerx Biopharmaceuticals Inc)
Issuance and Sale of the Securities. At the Closing, the Company shall issue and sell to the Investor, Investor and such the Investor shall purchase from the Company, Company (i) 1,296,296 1,219,512 Shares at a purchase price equal to $0.27 0.82 per Share (the “Purchase Price”), for aggregate gross proceeds of no more than $349,999.92 1,000,000 and (ii) a Warrant to purchase 518,518 609,756 Warrant Shares, representing 4050% of the Shares purchased by the Investorpurchased, at an exercise price of $0.38 1.12 per share.
Appears in 1 contract
Samples: Securities Purchase Agreement (Regenerx Biopharmaceuticals Inc)
Issuance and Sale of the Securities. At the Closing, the Company shall issue and sell to the Investor, Investor and such the Investor shall purchase from the Company, Company (i) 1,296,296 1,052,631 Shares at a purchase price equal to $0.27 0.57 per Share (the “Purchase Price”), for aggregate gross proceeds of no more than $349,999.92 600,000 and (ii) a Warrant to purchase 518,518 263,158 Warrant Shares, representing 4025% of the Shares purchased by the Investorpurchased, at an exercise price of $0.38 0.91 per share.
Appears in 1 contract
Samples: Securities Purchase Agreement (Regenerx Biopharmaceuticals Inc)